OMER: Omeros Corp. Price to Earnings Adjusted for Growth Rate

Corporate company logo of omeros.com (OMER)

Omeros Corporation (OMER) is implementing robots to accelerate molecular discovery while retaining its core scientific staff. Tracking the PEG ratio on the GURU.Markets platform confirms valuation stability, where 0.00 shows the current value of the metric. The financial model is based on the sale of licenses and ophthalmological instruments, as well as the development of drugs for the therapy of vascular and neurological pathologies.

OMER: Omeros Corporation Price/Earnings to Growth Ratio 07/04/2022 - 11/15/2026

Omeros Corp (OMER) - metric breakdowns and financial figures

- market price and analyst price targets:
- market capitalization information:
General company analysis:OMER (Omeros Corporation)
Core merchandise of Omeros

A conservative approach to analyzing Omeros Corporation (OMER) requires comparing market value with business expansion dynamics. This indicator divides the P/E ratio by the earnings growth rate, allowing the PEG ratio's average value to determine whether an investor is overpaying for scientific potential in the field of complement inhibitors, which is critical given the company's high R&D expenditures.

Competitors of Omeros Corporation

Growth-Adjusted Market Cap to Net Income Biogen Idec|Neurocrine Corp - Price/Earnings to Growth Multiple|regencellbioscience.com (RGC) - Price to Earnings Adjusted for Growth Rate|AXSM - Price/Earnings to Growth Ratio|ACAD (ACADIA Pharmaceuticals Inc.) - Growth-Adjusted P/E Ratio|Xenon Pharmaceuticals (XENE) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio VKTX|Price/Earnings to Growth Ratio Supernus|Price to Earnings Adjusted for Growth Rate catalystpharma.com CPRX|Price/Earnings to Growth Multiple DNLI (Denali Therapeutics Inc.)|HRMY - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Biohaven Ltd. BHVN|AMLX (Amylyx) - Market Cap to Earnings and Growth Ratio|Trevi Therapeutics Inc - PEG Multiple|Growth-Adjusted Payback Ratio PRAX (Praxis Precision Medicines)|AVXL: PEG Multiple|CBLL - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio prothena.com|Price/Earnings to Growth Multiple Alector (ALEC)|Price/Earnings to Growth Multiple ANNX (annexonbio.com)|Neurogene Inc. - Growth-Adjusted P/E Ratio|acimmune.com - Price/Earnings to Growth Multiple|PEG Multiple Voyager Therapeutics Inc VYGR|NMRA - Price/Earnings to Growth Ratio|Price to Net Income Growth Ratio Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio ACOG|Price/Earnings to Growth Ratio Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Multiple SAVA (Cassava)|Growth-Adjusted Market Cap to Net Income Assertio Therapeutics|Coya Therapeutics, Inc. - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - PEG Multiple|Acumen Pharmaceuticals, Inc. (ABOS) - Price/Earnings to Growth Multiple|CRVO (CervoMed, Inc.) - Price/Earnings to Growth Multiple|Price/Earnings to Growth Multiple Alterity Therapeutics Ltd|Price/Earnings to Growth Ratio Clene Inc.|PepGen Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Multiple JUNS (Jupiter Neurosciences Inc)|Price/Earnings to Growth Ratio RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income Grace Tx (GRCE)|fireflyneuro.com - PEG Multiple|Klotho Neurosciences (KLTO) - Price/Earnings to Growth Multiple|NeuroSense Therapeutics, Ltd. (NRSN) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - PEG Multiple|NRXS: Growth-Adjusted Payback Ratio|PEG Multiple HSDT|PEG Multiple Passage Bio Inc. (PASG)|Price/Earnings to Growth Ratio bionomics.com.au NEUP|PEG Multiple Minerva Neurosciences Inc NERV|ATHA: Price/Earnings to Growth Multiple|ADXN (Addex Therapeutics, Ltd.) - Growth-Adjusted P/E Ratio|Alzamend Neuro Inc. (ALZN) - Price/Earnings to Growth Ratio|Cyclerion - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio protagenic.com|Pasithea Therapeutics - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Multiple CRGT (Cortigent, Inc.)|Avenue Therapeutics - Growth-Adjusted P/E Ratio|Price/Earnings to Growth Ratio Brainstorm Cell BCLI|PEG Multiple caratherapeutics.com CARA|Chromocell Therapeutics Corp. - PEG Multiple|eliemtx.com - Company Value to Earnings Growth Ratio|Intra-Cellular Therapies (ITCI) - Price/Earnings to Growth Ratio|LBPH (Longboard) - Price/Earnings to Growth Ratio|MRNS (marinuspharma.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate NKGen Biotech NKGN|Price/Earnings to Growth Ratio NeuroBo Pharma (NRBO)|Company Value to Earnings Growth Ratio SAGE|Synaptogenix, Inc. - Price/Earnings to Growth Multiple|TRVN: Growth-Adjusted P/E Ratio|VIGL - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio WENA (Anew Medical, Inc.)|CERE: PEG Multiple